These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4808291

  • 1. Evaluation of drug abuse treatment and rehabilitation programs.
    Doran R.
    Proc Natl Conf Methadone Treat; 1973; 2():1374-8. PubMed ID: 4808291
    [No Abstract] [Full Text] [Related]

  • 2. [Methadone program in the USA. Experience and problems].
    Riedesser P.
    Med Klin; 1974 Apr 19; 69(16):671-80. PubMed ID: 4600421
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of treatment for drug abuse.
    Sells SB.
    Proc Natl Conf Methadone Treat; 1973 Apr 19; 2():1362-8. PubMed ID: 4808289
    [No Abstract] [Full Text] [Related]

  • 4. Increased utilization of counseling related to dose reduction in methadone maintenance.
    Creel S, Berkson R, Reilly J, Bulter P, Walker B, Carrozza L, Morrison J, O'Connell R, Patch V.
    Proc Natl Conf Methadone Treat; 1973 Apr 19; 2():957-62. PubMed ID: 4808326
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec 19; 12(68):235-6. PubMed ID: 14986702
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A report of over four years of experience in Hawaii. Methadone for heroin addiction.
    Quisenberry WB.
    Hawaii Med J; 1974 Nov 19; 33(11):409-11. PubMed ID: 4448628
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Value for money in drug treatment: economic evaluation of prison methadone.
    Warren E, Viney R, Shearer J, Shanahan M, Wodak A, Dolan K.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):160-6. PubMed ID: 16487668
    [Abstract] [Full Text] [Related]

  • 13. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
    Goldschmidt PG.
    Inquiry; 1976 Mar 15; 13(1):29-47. PubMed ID: 130347
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methadone treatment: views of program directors.
    Einstein S.
    Proc Natl Conf Methadone Treat; 1973 Mar 15; 1():718-22. PubMed ID: 4808225
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Refining cost benefit estimates of methadone programs.
    Backhaut B.
    Proc Natl Conf Methadone Treat; 1973 Mar 15; 2():1227-30. PubMed ID: 4808272
    [No Abstract] [Full Text] [Related]

  • 20. [The methadone program in Stockholm is repressive].
    Gunne L.
    Lakartidningen; 2001 Jul 11; 98(28-29):3251-3. PubMed ID: 11496816
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.